Cancer, Metastatic clinical trials at UC Cancer

• Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer

  open to eligible people ages 18 years and up

  The purpose of this study is to compare any good or bad effects of using pembrolizumab (an experimental drug) and radiation therapy (RT), compared to using cisplatin chemotherapy and radiation therapy (RT) in the treatment of patients with head and neck squamous cell carcinoma (HNSCC).

  at UCSD

• Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer

  open to eligible people ages 18 years and up

  This study will examine the combination of pembrolizumab and tadalafil for safety and efficacy in advanced head and neck cancer.

  at UCSD

Last updated: October 7, 2021